Alexander T Kozhich

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander T Kozhich. Retrieved from https://idiyas.com/inventor/alexander-t-kozhich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 9.9

ph-index = 7

Forward Citations = 147(Granted Patents)

Company Filing History:

13 out of 3,737

Bristol-Myers Squibb Compnay

patents

Years Active: 2014-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11813315 - Fibronectin based scaffold domain proteins that bind to myostatin (2023-11-14),

2. 11466092 - Antibodies against OX-40 and uses thereof (2022-10-11),

3. 10683357 - Antibodies against OX40 and uses thereof (2020-06-16),

4. 10451634 - Method of using human FC-bearing IGG antibodies to polyethylene glycol (2019-10-22),

5. 10406212 - Fibronectin based scaffold domain proteins that bind to myostatin (2019-09-10),

6. 10245302 - Fibronectin based scaffold domain proteins that bind to myostatin (2019-04-02),

7. 9804170 - Antibodies to polyethylene glycol (2017-10-31),

8. 9662373 - Fibronectin based scaffold domain proteins that bind to myostatin (2017-05-30),

9. 9644032 - Antibodies against OX40 and uses thereof (2017-05-09),

10. 9493546 - Fibronectin based scaffold domain proteins that bind to myostatin (2016-11-15),

11. 8993265 - Fibronectin based scaffold domain proteins that bind to myostatin (2015-03-31),

12. 8933199 - Fibronectin based scaffold domain proteins that bind to myostatin (2015-01-13),

13. 8853154 - Fibronectin based scaffold domain proteins that bind to myostatin (2014-10-07),

Title: Innovations and Contributions of Alexander T Kozhich

Introduction

Alexander T Kozhich is a prominent inventor based in Princeton, NJ (US), known for his significant contributions to the field of biotechnology. With a total of 13 patents to his name, Kozhich has made remarkable advancements that have the potential to impact various therapeutic applications.

Latest Patents

Among his latest patents is the invention of fibronectin-based scaffold domain proteins that bind to myostatin. This invention relates to the use of these proteins in therapeutic applications aimed at treating conditions such as muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. Additionally, he has developed antibodies against OX-40, which are crucial in therapeutic applications for cancer treatment. These patents also encompass cells that produce the antibodies, polynucleotides encoding the variable regions of the antibodies, and vectors that include these polynucleotides.

Career Highlights

Kozhich is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to the field of medical research. His work is characterized by a strong focus on developing solutions for complex health issues.

Collaborations

Throughout his career, Kozhich has collaborated with notable colleagues, including Martin J Corbett and Sharon T Cload, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Alexander T Kozhich's innovative work and numerous patents reflect his dedication to advancing medical science and improving patient outcomes. His contributions are paving the way for new therapeutic approaches in various health conditions.

Profile summary based on public USPTO records.